|
|
|
|
|
|
| H1NI vaccine to be ready by March-April: Azad | 03-NOV-09 |
|
| With swine flu claiming over 470 lives in the country till October-end, the Centre today said the much-awaited Influenza A-H1N1 vaccine to combat the viral disease would be ready by March-April next year. |
|
|
|
| Bharat Biotech's 'INDIRAB' vaccine sales doubles | 27-OCT-09 |
|
| Bharat Biotech, a leading manufacturer of vaccines and biotherapeutics, expects its Anti-Rabies vaccine INDIRAB to more than double its sales within the next two years as sales crossed the one crore doses sales mark. |
|
|
|
|
|
|
|
|
|
| Cadila-Novavax JV can produce 250 mn doses of H1N1 vaccine | 07-OCT-09 |
|
| CPL Biologicals, a joint venture between Ahmedabad based Cadila Pharmaceuticals and US based vaccine maker Novavax is aiming to roll out 10 million doses of swine flu vaccine (H1N1) in the first phase from January-February next year while it can ramp up the production to 250 million doses over a period of time. CPL Biologicals is creating a manufacturing facility at Dholka for about Rs 100 crore where it will produce for virus-like particle-based (VLP-based) vaccines including H1N1. Currently the company is awaiting a nod from Drug Controller General of India for conducting H1N1 clinical trails. |
|
|
|
|
|
|
| Bharat Biotech to test swine flu vaccine in 2 months | 28-SEP-09 |
|
| Hyderabad-based vaccines and biotherapeutics manufacturer Bharat Biotech, which is getting ready with an indigenous H1N1 swine flu candidate vaccine, would go for clinical trials in two months, according to its chairman and managing director Krishna M Ella. |
|
|
|
| Sanofi bags order from US for supplying swine flu vaccine | 22-SEP-09 |
|
| Sanofi Pasteur, the vaccine division of Sanofi-Aventis Group on Monday said it has received order from the US Department of Health and Human Services (HHS) to supply antigen for 27.3 million doses of Influenza A (H1N1) 2009 monovalent vaccine for swine flu. |
|
|
|
| 'H1N1 virus has not mutated, vaccines on track' | 21-SEP-09 |
|
| The head of the World Health Organisation (WHO) said today that the swine flu virus had apparently not yet mutated into a more serious disease and that the development of vaccines was proceeding on track. |
|
|
|
| Merck, UK Trust to set up vaccine research unit | 18-SEP-09 |
|
| Global pharma major Merck & Co has entered into a $130 million partnership with London-based Wellcome Trust to set up a not-for-profit research company in India. Merck operates in India as MSD Pharmaceuticals Pvt Ltd. |
|
|
|
| Few takers for govt offer on H1N1 vaccine trials | 17-SEP-09 |
|
| The central government’s invitation to global pharmaceutical companies to conduct clinical trials here of their H1N1 (swine flu) vaccine candidates has evoked only a limited response. Only two companies, Novartis and GlaxoSmithKline, have come forward to seek regulatory approval for such trials in India, it is learnt. |
|
|
|
| New drug fights flu as well as Tamiflu does: Study | 14-SEP-09 |
|
| Researchers delivered a double dose of good news today in the fight against flu — successful tests of what could become the first new flu medicine in a decade, and the strongest evidence yet that such drugs save lives, not just shorten illness. |
|
|
|
|
|
|
Content Guide
